United States · FDA National Drug Code directory
PREGABALIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71209-038_be6557c8-0d68-4313-a689-c2fdfb1d505e
- Product NDC
- 71209-038
- Form
- CAPSULE
- Composition / generic term
- PREGABALIN
- Labeler
- Cadila Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230713
- Source listing expiry
- 20261231
Source-listed ingredients
- PREGABALIN — 225 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 CAPSULE in 1 BOTTLE (71209-038-04) · 71209-038-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →